CQDM — PARTENAR-IA — Academic

This grant offers structured financing modalities designed to support collaborative biopharmaceutical R&D projects using artificial intelligence in Quebec. The financing is carefully determined to align with project scale and partnership dynamics.

• Maximum support rate is up to 50% of eligible expenses for both the business and the research institution involved.
• Financial support is capped at $350,000 per eligible partner business, with a total possible allocation of $1,500,000 for a project with five businesses.
• For projects involving two businesses, the maximum grant available is $700,000, contingent on the project's total value not exceeding $1.4 million.
• The project must secure a minimal industrial contribution of 25%, either in cash or in kind, from the participating businesses.

Eligibility for the Partenar-IA grant is determined by specific requirements that firms must meet to qualify.

• The project must involve a minimum of two businesses conducting R&D or production activities in Quebec.
• At least one of the participating businesses must be a small or medium-sized enterprise (SME) with at least 250 employees.
• The project must be carried out in collaboration with one or several research institutions in Quebec, ensuring at least 20% of the project's involvement is with these institutions, such as universities, hospitals, CCTTs, or public research centers.
• Each participating business is required to hire at least one intern per year for the duration of the project.
• The project must demonstrate a minimal industrial contribution of 25%, which can be in cash and/or in kind.
• External funding from non-MEIE sources can cover, at most, 25% of the project's funding arrangement.
• The project should have a maximum duration of 2 years.

Who is eligible?

This grant supports collaborative R&D projects in biopharmaceuticals using AI by businesses in Quebec.

• Collaborative projects between at least two businesses involved in biopharmaceutical R&D in Quebec, with participation from research institutions.
• Involvement of at least one SME with a minimum of 250 employees based in Quebec.
• Commitment to hire at least one intern per year throughout the project duration.
• Requirement for a minimum industrial contribution of 25% towards the project, either in cash or in kind.
• Projects receiving funding from other non-MEIE sources, capped at 25% of the total funding arrangement.
• Projects should have a maximum duration of 2 years.

Who is not eligible

Some companies may not be eligible for this grant due to specific exclusion criteria. For example, companies involved in tobacco, alcohol, or adult entertainment industries might not qualify.

• Companies engaged in illegal activities.
• Non-profit organizations.
• Companies not registered or operating in Canada.
• Government entities or agencies.

Eligible expenses

Partenar-IA grant is designed to support collaborative R&D projects in the biopharmaceutical sector in Quebec utilizing artificial intelligence. The program aims to foster collaboration between businesses and research institutions to advance technological innovations.

• Collaborative R&D projects involving AI applications in biopharmaceutical processes.
• Innovative projects enhancing drug discovery and development through machine learning and data analytics.
• Integration of AI technologies for improving healthcare outcomes and biomanufacturing efficiency.
• Initiatives involving interdisciplinary teams from industries and academic institutions.
• Projects contributing to the advancement of personalized medicine through AI-driven insights.

Eligible geographic areas

This grant is targeted towards businesses conducting activities in Quebec, reflecting regional development priorities and collaboration goals.

• Businesses with R&D or production activities within Quebec.

There are evaluation and selection criteria for this grant. The criteria include but are not limited to the applicant's innovation level, impact on the community, and financial viability.

• Applicant's innovation level
• Impact on the community
• Financial viability

Here are additional relevant details for this grant:

• Strong emphasis is placed on cross-sector collaboration between businesses and research institutions.
• Successful applicants may receive guidance and support from the grant provider throughout the project duration.
• The program aims to strengthen Quebec's position in the biopharmaceutical and AI sectors.
• Projects should demonstrate potential for significant advancements or innovations in biopharmaceutical applications.